SHSE:688273 (China)
Â
Class A
Â¥
30.01
-2.11 (-6.57%)
Jul 20
Business Description
Nanjing Medlander Medical Technology Co Ltd
ISIN : CNE100005PV8
Share Class Description:
SHSE:688273: Class ATotal Employee Number:
550Compare
Compare
Traded in other countries / regions
688273.China Index Membership
SSE Composite Index IPO Date
2022-08-11Description
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 22.13 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.4 | |||||
Interest Coverage | 60.45 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.82 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.8 | |||||
3-Year EBITDA Growth Rate | -10 | |||||
3-Year EPS without NRI Growth Rate | -8.4 | |||||
3-Year Book Growth Rate | -0.1 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.35 | |||||
9-Day RSI | 32.35 | |||||
14-Day RSI | 34.84 | |||||
3-1 Month Momentum % | -14.11 | |||||
6-1 Month Momentum % | -12.1 | |||||
12-1 Month Momentum % | 36.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.89 | |||||
Quick Ratio | 4.51 | |||||
Cash Ratio | 4.18 | |||||
Days Inventory | 196.53 | |||||
Days Sales Outstanding | 28.16 | |||||
Days Payable | 138.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.67 | |||||
Dividend Payout Ratio | 0.76 | |||||
3-Year Dividend Growth Rate | 11.9 | |||||
Forward Dividend Yield % | 4 | |||||
5-Year Yield-on-Cost % | 2.67 | |||||
Shareholder Yield % | 2.04 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.23 | |||||
Operating Margin % | 20.63 | |||||
Net Margin % | 20.77 | |||||
EBITDA Margin % | 21.44 | |||||
FCF Margin % | 2.15 | |||||
OCF Margin % | 22.53 | |||||
ROE % | 6.33 | |||||
ROA % | 5.47 | |||||
ROIC % | 11.57 | |||||
3-Year ROIIC % | -4.12 | |||||
ROC (Joel Greenblatt) % | 20.77 | |||||
ROCE % | 6.23 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 34.26 | |||||
Forward PE Ratio | 18.19 | |||||
PE Ratio without NRI | 32.48 | |||||
Price-to-Owner-Earnings | 145.68 | |||||
PS Ratio | 7.11 | |||||
PB Ratio | 2.19 | |||||
Price-to-Tangible-Book | 2.36 | |||||
Price-to-Free-Cash-Flow | 333.45 | |||||
Price-to-Operating-Cash-Flow | 31.59 | |||||
EV-to-EBIT | 25.69 | |||||
EV-to-EBITDA | 25.69 | |||||
EV-to-Revenue | 5.51 | |||||
EV-to-FCF | 256.24 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Graham-Number | 1.85 | |||||
| Price-to-Net-Current-Asset-Value | 4.45 | |||||
| Price-to-Net-Cash | 5.55 | |||||
Earnings Yield (Greenblatt) % | 3.89 | |||||
FCF Yield % | 0.3 | |||||
Forward Rate of Return (Yacktman) % | -9.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Medlander Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 412.516 | ||
| EPS (TTM) (Â¥) | 0.876 | ||
| Beta | 1.9365 | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.22 | ||
| Volatility % | 50.11 | ||
| 14-Day RSI | 34.84 | ||
| 14-Day ATR (Â¥) | 2.880794 | ||
| 20-Day SMA (Â¥) | 38.1105 | ||
| 12-1 Month Momentum % | 36.36 | ||
| 52-Week Range (Â¥) | 29.29 - 61.22 | ||
| Shares Outstanding (Mil) | 100 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanjing Medlander Medical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanjing Medlander Medical Technology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.500000 Cash Dividend | 2026-05-26 | 43.09 (-1.62%) | ||
| CNY 0.300000 Cash Dividend | 2025-11-27 | 35.17 (-1.12%) | ||
| CNY 0.400000 Cash Dividend | 2025-06-17 | 28.30 (+1.04%) | ||
| CNY 0.400000 Cash Dividend | 2024-10-08 | 25.97 (+8.16%) |
Show
Entries
Nanjing Medlander Medical Technology Co Ltd Frequently Asked Questions
What is Nanjing Medlander Medical Technology Co Ltd(SHSE:688273)'s stock price today?
The current price of SHSE:688273 is ¥30.01. The 52 week high of SHSE:688273 is ¥61.22 and 52 week low is ¥29.29.
When is next earnings date of Nanjing Medlander Medical Technology Co Ltd(SHSE:688273)?
The next earnings date of Nanjing Medlander Medical Technology Co Ltd(SHSE:688273) is .
Does Nanjing Medlander Medical Technology Co Ltd(SHSE:688273) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Medlander Medical Technology Co Ltd(SHSE:688273) is 2.67% (As of Today), Highest Dividend Payout Ratio of Nanjing Medlander Medical Technology Co Ltd(SHSE:688273) was 1.2. The lowest was 0.47. And the median was 0.99. The  Forward Dividend Yield % of Nanjing Medlander Medical Technology Co Ltd(SHSE:688273) is 4%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nanjing Medlander Medical Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers